Overview

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

Status:
Not yet recruiting
Trial end date:
2030-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.
Phase:
Phase 4
Details
Lead Sponsor:
Takeshi Morimoto
Treatments:
Aspirin